Novavax

Develops vaccines, including a COVID-19 shot now sold by Sanofi.

Company Health

/100

Weak

A quick check of the business from its yearly reports (2022–2025). It doesn’t say whether the stock is a good buy.

Does it make money?

25 of 25 · Good

$39 of every $100 in sales was left as profit last year.

Is it growing?

0 of 25 · Poor

Sales shrank about 17% a year over the last 3 years.

Can it handle what it owes?

0 of 25 · Poor

Its business used cash last year, and it owes $111 of every $100 it owns.

Who owns it

1 of 23 own it · Nobody changed their stake

bought lately

owns it

doesn’t own it

Didn’t report owning it: Whale Rock, Appaloosa, Melqart, D1 Capital, Light Street, Lone Pine, Third Point, TCI, Pershing Square, Duquesne, Himalaya Capital, Greenlight, Giverny Capital, Fundsmith, Semper Augustus, Akre

Their letters don’t mention it: Arquitos, Laughing Water, Alluvial, Bireme, Kingdom Capital, Saga Partners

From each fund’s latest 13F report (Jun 30, 2026). Funds that don’t file one: from their own letters.

The numbers

From Novavax’s yearly reports. Tap a year to see its figures.

Sales and profit

Sales grew from $476 million in 2020 to $1.12 billion in 2025, and it made a profit in 1 of the 6 years.

2025

Sales

$1.12 billion

Profit

$440 million

Spare cash each year

It had cash to spare in 1 of the 2 years, including $265 million in 2021.

2025

Not reported

Spare cash is the cash its business brought in, minus what it spent on buildings and equipment. Some years don’t say what it spent, so those bars may be a little high.

What it owns and what it owes

At the end of 2025 it owed $1.30 billion, more than everything it owned ($1.18 billion).

Key facts

From its yearly report for 2025.

Sales

$1.12 billion

Profit

$440 million

Cash in the bank

$241 million

Everything it owes

$1.30 billion

Year ends

December

Money shown in

U.S. dollars

Latest yearly report

10-K, filed Feb 26, 2026

Figures from Novavax’s yearly reports to the SEC (EDGAR), collected Oct 12, 2026.

Not investment advice. Holdings come from public SEC reports and the funds’ own letters, and can be up to 4½ months old. How this works